Introduction
============

Chronic hepatitis B virus (HBV) infection continues to make a substantial contribution to the global burden of disease.[@R1]^,^[@R2] The risk of developing chronic HBV is inversely related to the age at acquisition of infection.[@R3]^,^[@R4] Immunization is the most effective measure to prevent the transmission of HBV.[@R5]^,^[@R6] In 2014, the World Health Organization (WHO) reaffirmed the need for hepatitis B vaccines to become an integral part of national immunization schedules.[@R7] WHO recommends a birth dose within 24 hours of birth to prevent perinatal and early horizontal HBV transmission.[@R8] The birth dose should be followed by 2 or 3 doses of monovalent or multivalent hepatitis B vaccines.[@R8]

Vaccination coverage estimates from WHO and the United Nations Children's Fund (UNICEF) capture the proportion of vaccinated children in specific age groups. However, these estimates provide little insight into the extent to which vaccinations are administered on time and they tend to understate the susceptibility to HBV infection in a population.[@R9]^--^[@R11] In practice, vaccinations are more likely to be received late than early.[@R12]^,^[@R13] When hepatitis B vaccination is delayed, children fail to receive adequate protection when they are most vulnerable. Moreover, by increasing the period of susceptibility to infection,[@R8] late vaccinations raise the risk of HBV infection[@R14] and hence the risk of chronicity. Furthermore, a delay in one dose may lead to delays in further doses,[@R15] thereby extending the at-risk period. This has important implications in countries that are highly endemic for HBV infection. In this situation, catch-up vaccination of older children has relatively little impact because they might already be infected by the time they present for vaccination.[@R8]

There are multiple options for incorporating hepatitis B vaccines into national immunization programmes and the choice of vaccination schedule depends primarily on programmatic considerations.[@R8] From a policy perspective, data from a large number of countries are necessary to evaluate the impact of existing hepatitis B vaccination schedules and vaccine types on hepatitis B vaccination timing. Thus far, analyses of hepatitis B vaccinations have been limited in scope[@R16]^--^[@R18] and have not tackled this aspect. The demographic and health surveys (DHS) provide data on childhood vaccinations based on vaccination cards and maternal interviews. Data compiled through DHS are nationally representative and are considered to be the best available data on vaccination coverage.[@R19] We estimated vaccination coverage and timing, and examined the impact of hepatitis B vaccination schedules and vaccine types on vaccination timing in countries for which DHS data were publicly available.

Methods
=======

Study design
------------

Full details of DHS methods have been reported elsewhere.[@R20]^,^[@R21] DHS data on hepatitis B vaccination were available for 54 countries. For every country, we used the most recent survey available until the end of 2015. Seven surveys were excluded due to incomplete data or non-standard recording of dates. We therefore included 47 countries with survey years ranging from 2005 to 2014. We grouped countries based on their vaccination schedule and type of vaccine (monovalent or combination) in use ([Table 1](#T1){ref-type="table"}, available at <http://www.who.int/bulletin/volumes/95/3/16.178822>). In countries that had altered their schedules before the DHS survey we limited our analyses to the more established vaccination schedule.

###### Background characteristics and sampling for the 47 low- and middle-income countries surveyed, by national hepatitis B vaccination schedule

  Vaccination schedule^a^ and vaccine type   Country                            WHO Region   Country data   DHS survey year   Sample of children aged 12--60 months, no.^f^                 
  ------------------------------------------ ---------------------------------- ------------ -------------- ----------------- ----------------------------------------------- ------ ------ ---------
  **Weeks 0, 4, 13**                                                                                                                                                                        
  Monovalent                                 Maldives                           SEAR         No             Upper-middle      332 575                                         N/A    2009   2 498
  **Weeks 0, 4, 26**                                                                                                                                                                        
  Monovalent                                 Republic of Moldova                EUR          No             Lower-middle      3 573 024                                       7.4    2005   1 165
  **Weeks 0, 6, 14**                                                                                                                                                                        
  Monovalent                                 Nigeria                            AFR          No             Lower-middle      159 707 780                                     9.8    2013   20 799
  **Weeks 0, 6, 26**                                                                                                                                                                        
  Monovalent                                 Armenia                            EUR          Yes            Lower-middle      2 963 496                                       N/A    2010   1 114
  **Weeks 0, 9, 17**                                                                                                                                                                        
  Monovalent                                 Azerbaijan                         EUR          Yes            Upper-middle      9 094 718                                       2.8    2006   1 707
  Monovalent                                 Tajikistan                         EUR          Yes            Lower-middle      7 627 326                                       7.2    2012   3 797
  **Weeks 0, 9, 22**                                                                                                                                                                        
  Monovalent                                 Kyrgyzstan                         EUR          Yes            Lower-middle      5 334 223                                       10.3   2012   3 174
  **Weeks 0, 9, 26**                                                                                                                                                                        
  Monovalent                                 Albania                            EUR          Yes            Upper-middle      3 150 143                                       7.8    2008   1 303
  **Weeks 4, 8, 12**                                                                                                                                                                        
  Tetravalent                                United Republic of Tanzania        AFR          Yes            Low               44 973 330                                      7.2    2010   5 444
  Pentavalent                                Uganda                             AFR          Yes            Low               33 987 213                                      9.2    2011   1 586
  **Weeks 6, 10, 14**                                                                                                                                                                       
  Monovalent                                 Bangladesh                         SEAR         Yes            Lower-middle      151 125 475                                     3.1    2011   6 400
  Monovalent                                 Cameroon                           AFR          Yes            Lower-middle      20 624 343                                      12.2   2011   3 803
  Monovalent                                 Gabon                              AFR          No             Upper-middle      1 556 222                                       11.5   2012   2 605
  Monovalent                                 Lesotho                            AFR          Yes            Lower-middle      2 010 586                                       N/A    2009   1 263
  Monovalent                                 Pakistan                           EMR          Yes            Lower-middle      173 149 306                                     2.8    2012   2 865
  Monovalent                                 Swaziland                          AFR          No             Lower-middle      1 193 148                                       19.0   2006   1 610
  Monovalent                                 Timor-Leste                        SEAR         No             Lower-middle      1 057 122                                       N/A    2009   7 168
  Bivalent                                   Benin                              AFR          Yes            Low               9 509 798                                       15.6   2011   6 571
  Tetravalent                                Madagascar                         AFR          Yes            Low               21 079 532                                      4.6    2008   4 269
  Tetravalent                                Mozambique                         AFR          Yes            Low               23 967 265                                      8.3    2011   7 412
  Pentavalent                                Burundi                            AFR          Yes            Low               9 232 753                                       9.1    2010   2 625
  Pentavalent                                Cambodia^g^                        WPR          Yes            Lower-middle      14 364 931                                      4.1    2014   3 487
  Pentavalent                                Comoros                            AFR          Yes            Low               698 695                                         N/A    2012   2 100
  Pentavalent                                Côte d'Ivoire                      AFR          Yes            Lower-middle      18 976 588                                      9.4    2011   2 383
  Pentavalent                                Democratic Republic of the Congo   AFR          Yes            Low               62 191 161                                      6.0    2013   6 462
  Pentavalent                                Ghana                              AFR          Yes            Lower-middle      24 262 901                                      12.9   2014   2 103
  Pentavalent                                Kenya                              AFR          Yes            Lower-middle      40 909 194                                      5.2    2008   3 965
  Pentavalent                                Liberia                            AFR          Yes            Low               3 957 990                                       17.6   2013   2 469
  Pentavalent                                Malawi                             AFR          Yes            Low               15 013 694                                      12.2   2010   3 945
  Pentavalent                                Mali                               AFR          Yes            Low               13 985 961                                      13.1   2012   3 700
  Pentavalent                                Namibia                            AFR          No             Upper-middle      2 178 967                                       8.6    2013   1 357
  Pentavalent                                Niger                              AFR          Yes            Low               15 893 746                                      15.5   2012   2 282
  Pentavalent                                Rwanda                             AFR          Yes            Low               10 836 732                                      6.7    2010   3 259
  Pentavalent                                Senegal                            AFR          Yes            Low               12 950 564                                      11.1   2014   4 246
  Pentavalent                                Sierra Leone^g^                    AFR          Yes            Low               5 751 976                                       8.4    2013   3 606
  Pentavalent                                Zambia                             AFR          Yes            Lower-middle      13 216 985                                      6.1    2013   9 562
  **Weeks 9, 13, 17**                                                                                                                                                                       
  Monovalent                                 Jordan                             EMR          No             Upper-middle      6 454 554                                       1.9    2012   5 380
  Pentavalent                                Burkina Faso                       AFR          Yes            Low               15 540 284                                      12.1   2010   5 113
  Pentavalent                                Congo                              AFR          Yes            Lower-middle      4 111 715                                       11.0   2011   3 508
  **Weeks 9, 17, 26**                                                                                                                                                                       
  Monovalent                                 Egypt                              EMR          No             Lower-middle      78 075 705                                      1.7    2014   11 639
  Monovalent                                 Colombia^g^                        AMR          No             Upper-middle      46 444 798                                      2.3    2010   12 615
  Pentavalent                                Bolivia (Plurinational State of)   AMR          No             Lower-middle      10 156 601                                      0.4    2008   6 396
  Pentavalent                                Dominican Republic^g^              AMR          No             Upper-middle      10 016 797                                      4.1    2013   2 597
  Pentavalent                                Guyana                             AMR          Yes            Upper-middle      753 362                                         N/A    2009   1 449
  Pentavalent                                Honduras                           AMR          No             Lower-middle      7 503 875                                       N/A    2011   7 998
  Pentavalent                                Peru^g^                            AMR          No             Upper-middle      29 262 830                                      2.1    2012   7 513
  **Weeks 13, 17, 22**                                                                                                                                                                      
  Pentavalent                                Zimbabwe                           AFR          Yes            Low               13 076 978                                      14.4   2010   3 331
  **Overall**                                N/A                                N/A          N/A            N/A               1 161 836 962                                   N/A    N/A    211 643

AFR: African Region; AMR: Region of the Americas; DHS: Demographic Health Survey; EMR: Eastern Mediterranean Region; EUR: European Region; Gavi: Gavi, the Vaccine Alliance; HBsAg: surface antigen of the hepatitis B virus; N/A: data not available or not applicable; SEAR: South-East Asia Region; WPR: Western Pacific Region; WHO: World Health Organization.

^a^ Schedule is the target weeks after birth to administer the first, second and third doses of vaccine. Details of national immunization schedules were obtained from relevant annual joint World Health Organization (WHO) and United Nations Children's Fund (UNICEF) immunization reports and demographic and health surveys for each country. Vaccine types were: monovalent (hepatitis B); bivalent (hepatitis B and *Haemophilus influenzae* type b); tetravalent (hepatitis B and diphtheria--tetanus--pertussis); pentavalent (diphtheria--tetanus--pertussis, hepatitis B and *Haemophilus influenzae* type b).

^b^ Gavi financing was recorded as "Yes" if the country received new and underused vaccine support for either monovalent or pentavalent vaccines (<http://www.gavi.org/country/>).

^c^ Country income level was defined as per the World Bank.[@R22]

^d^ Population estimates were obtained from the United Nations.[@R23]

^e^ Data on HBsAg prevalence (general population aged 0--85 years) are the most recent global prevalence estimates from 1965--2014 obtained from Schweitzer et al.[@R2]

^f^ Sample sizes (number of children aged 12‒60 months) are unweighted.

^g^ Vaccination schedule in these countries includes a birth dose of hepatitis B vaccine (monovalent), i.e. four doses in total.

Notes: We examined data quality for all children covered by the surveys. Vaccination dates were counted as invalid if day, month or year were missing, or if the date was implausible, e.g. before the date of birth of the child or after the date of mother's interview or with erroneous dates (e.g. as year 9998). We only considered vaccination cards as available if seen by the interviewer. Excluded surveys: Ethiopia (non-standard date recording), Indonesia (date of birth not available), Morocco (only first dose reported), Nepal (non-standard date recording), Nicaragua (key missing variables, e.g. wealth index), Philippines (date of birth not available),and Turkey (date of birth not available). Countries that altered their national immunization schedules within 5 years of the survey were: Armenia (pentavalent introduced in 2009), Gabon (pentavalent introduced in 2010), Kyrgyzstan (pentavalent introduced in 2009) and Tajikistan (pentavalent introduced in 2008--09). Hence, we adopted the previous immunization schedule for these nations in our analysis. For Cambodia and Colombia, and the United Republic of Tanzania, data on multiple vaccine types (monovalent and combination) were reported. We based our estimates on monovalent vaccination in Colombia, pentavalent in Cambodia and tetravalent in the United Republic of Tanzania. The decision was based on schedules (vaccines) reported in the relevant annual UNICEF/WHO immunization reports and the available data sets.

We identified and analysed individual vaccine doses according to the respective country's national immunization schedule. To assess vaccination coverage, we used only documented vaccinations (with or without specific dates marked) for each vaccine dose. Vaccination coverage was categorized as complete if the child was recorded as fully immunized with three or four doses of the vaccine according to the country's national immunization schedule. Vaccination coverage was categorized as incomplete if any of the recommended doses were recorded as 0 (not given), including when data on other doses was missing.[@R8] We excluded children younger than 12 months to avoid the drawback of censored observations. The denominator for coverage was the DHS sample of surviving children born in the past 5 years before the survey (or sometimes 3 years, depending on the DHS interval). To address potential bias from maternal recall,[@R24]^,^[@R25] we estimated crude vaccination coverage and completeness (from vaccination card plus maternal recall).

To assess vaccination timing, we compared each child's recorded vaccination dates with those recommended in the country's national immunization schedule. Age at vaccination was determined by subtracting the child's date of birth from valid vaccination dates. Vaccinations were categorized as timely if administered within 4 weeks of the recommended age, or delayed if administered more than 4 weeks after the recommended age. We calculated the percentage of children receiving delayed or timely vaccinations. The denominator for calculating timing included children vaccinated early, i.e. before the recommended age. National immunization schedules often do not specify when to give the birth-dose vaccine.[@R26] We therefore defined a timely birth dose as received within 7 days after delivery, based on the evidence on effective prevention of perinatal hepatitis B transmission.[@R27] We also computed estimates based on the WHO recommendation of giving hepatitis B vaccine within 24 hours of birth.[@R8]

Statistical analysis
--------------------

We performed all analyses with the survey functions of Stata statistical software, version 14 (Stata Corp., College Station, United States of America), using a significance level of ≤ 0.05.

We took account of the complex DHS survey design and used sample weights provided in the available data sets. Using Spearman rank correlations, we analysed the relationship between vaccination timing and coverage of the third dose of vaccine across countries.

We then used binary multivariable logistic regression models to calculate adjusted odds ratios (aOR) and 95% confidence intervals (CI) to investigate the impact of vaccination schedule and vaccine type on hepatitis B vaccination timing. Vaccinations were dichotomized as delayed or timely. We constructed pooled models for two outcomes: delayed first dose and delayed third dose. The main independent variables were the recommended week of the vaccination schedule and vaccine type (monovalent or combination). We categorized reported vaccination schedules as follows: starting at birth i.e. ≤ 1 week of age (reference category), 4, 6, 9 and 13 weeks, respectively. We incorporated covariates chosen for their possible or demonstrated associations with vaccination measures.[@R16]^,^[@R28] In an additional pooled model, we assessed the impact of the timing of the first dose on the timing of the third dose. The dependent variable was timing of the third dose and the main independent variable was timing of the first dose.

Results
=======

Data were analysed for 211 643 children aged 12--60 months who had valid records of date of birth and date of mother's interview. The median survey year was 2012 (interquartile range, IQR: 2010 to 2013). Reported vaccination dates were almost all complete and valid. Overall, vaccination cards were available for 123 679 (weighted count) of the children aged 12--60 months.

At the time of the surveys, 24 countries used the three-dose standard schedule for hepatitis B vaccine (doses at 6, 10 and 14 weeks), four countries vaccinated at 9, 17 and 26 weeks and the remaining countries used other three-dose schedules, some of which included an extra dose at birth, i.e. four doses in total ([Table 1](#T1){ref-type="table"}). Thirteen countries reported a vaccine dose at birth; eight included a birth dose in their three-dose schedule and five used a four-dose schedule. Combination vaccine, mostly a pentavalent vaccine, was used in 29 countries, while monovalent vaccine was used in 18 countries.

[Fig. 1](#F1){ref-type="fig"} shows the pooled distribution of ages at vaccination for 108 626 (first dose) and 101 542 (third dose) children aged 12--60 months at the time of the mother's interview, using data from vaccination cards only. Both the first and third doses had peak numbers of children vaccinated around the recommended target ages, followed by tails to the right, indicating delays in vaccination. The different peaks in the distributions of first and third doses reflect the diverse immunization schedules and recommended target ages for these doses across the 47 countries.

![Age at administration of first and third doses of hepatitis B vaccine for all vaccination schedules for children aged 12--60 months in all 47 countries](BLT.16.178822-F1){#F1}

Coverage of the birth dose ranged from 26% to 99% of children across the 13 countries using this dose. The percentage of children receiving birth-dose vaccinations on time ranged from 23% to 94% across countries ([Fig. 2](#F2){ref-type="fig"}). The proportion of timely vaccinations was lower when we defined the birth dose as administered within 24 hours rather than within 7 days of birth.

![Coverage and timing of birth dose of hepatitis B vaccine for children aged 12--60 months in 13 countries with national vaccination schedules including a vaccine dose at birth](BLT.16.178822-F2){#F2}

Vaccination coverage
--------------------

Coverage for all doses, and for complete coverage varied greatly, even across countries following the same vaccination schedule and vaccine type ([Table 2](#T2){ref-type="table"}, available at <http://www.who.int/bulletin/volumes/95/3/16.178822>). For example, complete coverage for countries using the 6-, 10-, and 14-week schedule ranged from 13% in Mali to 93% in Swaziland. Overall, we recorded a drop in coverage in particular of the third dose compared to the first dose, irrespective of the vaccination schedule and vaccine type in use. This was particularly prominent in some countries, such as Azerbaijan (where coverage dropped from 69% to 48%) and Côte d'Ivoire (from 74% to 58%).

###### Coverage of doses of hepatitis B vaccine for children aged 12--60 months in 47 low- and middle-income countries based on vaccination cards, by national hepatitis B vaccination schedule

  Vaccination schedule^a^ and vaccine type   Country                            First dose                  Second dose             Third dose        Complete^b^                               
  ------------------------------------------ ---------------------------------- ------------ -------------- ------------- --------- -------------- -- ------------- -------------- -- --------- -------------
  **Weeks 0, 4, 13**                                                                                                                                                                            
  Monovalent                                 Maldives                           2 073        2 042 (99)                   2 079     2 041 (98)        2 078         2 037 (98)        2 078     2 034 (98)
  **Weeks 0, 4, 26**                                                                                                                                                                            
  Monovalent                                 Republic of Moldova                1 045        1 040 (100)                  1 086     1 068 (98)        1 095         1 062 (97)        1 057     1 025 (97)
  **Weeks 0, 6, 14**                                                                                                                                                                            
  Monovalent                                 Nigeria                            14 623       3 735 (26)                   15 223    3 442 (23)        16 133        3 113 (19)        15 922    2 880 (18)
  **Weeks 0, 6, 26**                                                                                                                                                                            
  Monovalent                                 Armenia                            1 041        1 016 (98)                   1 042     979 (94)          1 049         943 (90)          1 048     943 (90)
  **Weeks 0, 9, 17**                                                                                                                                                                            
  Monovalent                                 Azerbaijan                         1 106        760 (69)                     1 229     721 (65)          1 300         622 (48)          1 292     567 (44)
  Monovalent                                 Tajikistan                         3 323        3 026 (91)                   2 953     2 780 (94)        3 025         2 750 (91)        3 180     2 740 (86)
  **Weeks 0, 9, 22**                                                                                                                                                                            
  Monovalent                                 Kyrgyzstan                         2 393        2 247 (94)                   2 207     2 136 (97)        2 268         2 055 (91)        2 330     2 036 (87)
  **Weeks 0, 9, 26**                                                                                                                                                                            
  Monovalent                                 Albania                            848          813 (96)                     886       814 (92)          925           772 (83)          913       759 (83)
  **Weeks 4, 8, 12**                                                                                                                                                                            
  Tetravalent                                United Republic of Tanzania        4 424        3 394 (77)                   4 465     3 351 (75)        4 565         3 247 (71)        4 556     3 230 (71)
  Pentavalent                                Uganda                             905          809 (89)                     957       770 (80)          1 107         710 (64)          1 106     695 (63)
  **Weeks 6, 10, 14**                                                                                                                                                                           
  Monovalent                                 Bangladesh                         3 790        3 592 (95)                   3 817     3 532 (93)        3 881         3 446 (89)        3 873     3 438 (89)
  Monovalent                                 Cameroon                           2 457        1 751 (71)                   2 618     1 697 (65)        2 856         1 614 (57)        2 861     1 606 (56)
  Monovalent                                 Gabon                              1 732        802 (46)                     1 828     741 (41)          1 870         630 (34)          1 886     624 (33)
  Monovalent                                 Lesotho                            877          747 (85)                     849       696 (82)          852           657 (77)          876       642 (73)
  Monovalent                                 Pakistan                           1 636        561 (34)                     1 704     527 (31)          1 904         513 (27)          1 903     513 (27)
  Monovalent                                 Swaziland                          1 395        1 348 (97)                   1 400     1 335 (95)        1 422         1 318 (93)        1 422     1 317 (93)
  Monovalent                                 Timor-Leste                        4 165        2 107 (51)                   4 416     2 068 (47)        4 836         2 030 (42)        4 806     2 004 (42)
  Bivalent                                   Benin                              6 390        2 355 (37)                   6 385     2 263 (35)        6 382         2 146 (34)        6 378     2 122 (33)
  Tetravalent                                Madagascar                         2 643        2 030 (77)                   2 748     1 994 (73)        2 919         1 924 (66)        2 886     1 888 (65)
  Tetravalent                                Mozambique                         6 249        5 539 (89)                   6 326     5 330 (84)        6 598         5 034 (76)        6 604     5 007 (76)
  Pentavalent                                Burundi                            1 418        1377 (97)                    1 418     1 354 (95)        1 457         1 336 (92)        1 457     1 332 (91)
  Pentavalent                                Cambodia^c^                        2 646        2 443 (92)                   2 702     2 382 (88)        2 798         2 287 (82)        2 701     1 872 (69)
  Pentavalent                                Comoros                            1 509        1 090 (72)                   1 556     1 065 (68)        1 702         1 037 (61)        1 675     1 007 (60)
  Pentavalent                                Democratic Republic of the Congo   2 246        1 017 (45)                   2 590     962 (37)          3 305         894 (27)          3 301     888 (27)
  Pentavalent                                Côte d'Ivoire                      1 846        1 364 (74)                   1 893     1 273 (67)        1 929         1 122 (58)        1 917     1 114 (58)
  Pentavalent                                Ghana                              1 672        1 588 (95)                   1 716     1 580 (92)        1 829         1 541 (84)        1 819     1 526 (84)
  Pentavalent                                Kenya                              2 647        2 430 (92)                   2 733     2 403 (88)        2 892         2 321 (80)        2 851     2 276 (80)
  Pentavalent                                Liberia                            1 079        863 (80)                     1 164     812 (70)          1 411         751 (53)          1 405     745 (53)
  Pentavalent                                Malawi                             2 547        2 395 (94)                   2 599     2 404 (92)        2 665         2 367 (89)        2 642     2 331 (88)
  Pentavalent                                Mali                               3 627        498 (14)                     3 623     479 (13)          3 629         464 (13)          3 629     454 (13)
  Pentavalent                                Namibia                            893          855 (96)                     934       849 (91)          971           835 (86)          969       834 (86)
  Pentavalent                                Niger                              1 504        1 155 (77)                   1 560     1 113 (71)        1 693         1 066 (63)        1 694     1 062 (63)
  Pentavalent                                Rwanda                             3 030        2 417 (80)                   3 044     2 406 (79)        3 063         2 375 (78)        3 056     2 366 (77)
  Pentavalent                                Senegal                            2 472        2 290 (93)                   2 468     2 224 (90)        2 472         2 108 (85)        2 467     2 098 (85)
  Pentavalent                                Sierra Leone^c^                    2 325        2 087 (90)                   2 397     2 040 (85)        2 666         1 909 (72)        2 521     882 (35)
  Pentavalent                                Zambia                             6 872        6 468 (94)                   6 917     6 307 (91)        7 133         6 021 (84)        7 105     5 929 (83)
  **Weeks 9, 13, 17**                                                                                                                                                                           
  Monovalent                                 Jordan                             3 645        3 620 (99)                   3 642     3 584 (98)        3 646         3 567 (98)        3 647     3 558 (98)
  Pentavalent                                Congo                              1 684        1 170 (69)                   1 841     1 142 (62)        2 128         1 026 (48)        2 118     1 017 (48)
  Pentavalent                                Burkina Faso                       3 823        3 450 (90)                   3 845     3 399 (88)        3 945         3 352 (85)        3 936     3 341 (85)
  **Weeks 9, 17, 26**                                                                                                                                                                           
  Monovalent                                 Egypt                              4 875        4 722 (97)                   4 655     4 424 (95)        4 663         4 214 (90)        4 559     4 083 (90)
  Monovalent                                 Colombia^c^                        9 036        8 472 (94)                   9 101     8 355 (92)        10 189        8 199 (80)        9 910     6 576  (66)
  Pentavalent                                Bolivia (Plurinational State of)   4 846        4 668 (96)                   4 955     4 546 (92)        5 126         4 338 (85)        5 109     4 316 (84)
  Pentavalent                                Dominican Republic^c^              1 797        1 441 (80)                   1 824     1 338 (73)        1 997         1 228 (61)        2 039     1 018 (50)
  Pentavalent                                Guyana                             1 149        1 044 (91)                   1 170     1 049 (90)        1 198         1 018 (85)        1 183     1 004 (85)
  Pentavalent                                Honduras                           6 561        6 521 (99)                   6 581     6 486 (99)        6 631         6 448 (97)        6 563     6 369 (97)
  Pentavalent                                Peru^c^                            5 576        4 260 (76)                   5 727     4 190 (73)        5 962         4 080 (68)        5 888     2 926 (50)
  **Weeks 13, 17, 22**                                                                                                                                                                          
  Pentavalent                                Zimbabwe                           2 503        1 842 (74)                   2 559     1 777 (69)        2 654         1 682 (63)        2 660     1 661 (62)
  **Overall (weighted counts)**              N/A                                146 943      111 261 (76)                 149 432   108 229 (72)      156 819       104 209 (66)      155 798   98 655 (63)

N/A: not applicable.

^a^ Schedule is the target weeks after birth to administer the first, second and third doses of vaccine.

^b^ Vaccination coverage was categorized as complete if the child was recorded as fully immunized with at least three doses of monovalent or combination hepatitis B vaccine. Incomplete coverage was if any of the recommended doses was recorded as 0 (not given), irrespective of whether other doses were missing response items; for instance, if dose 1 and 2 were missing but dose 3 was recorded as 0 we considered the individual as incompletely vaccinated.

^c^ Vaccination schedule in these countries includes a birth dose of hepatitis B vaccine (monovalent), i.e. four doses in total.

Notes: Data were extracted from the most recent demographic and health survey in each country (survey year range: 2005--2014). Denominators are weighted counts of the number of children and are based on children with vaccination dates or vaccinations marked as administered in the vaccination card but without dates. Denominators for individual vaccine doses vary due to the number of observations (children) reporting specific doses as not received and the number of children for whom doses were reported as received.

Vaccination delays
------------------

We observed a substantial variation in delays in receipt of the first and third doses across countries having the same vaccination schedule and vaccine type ([Table 3](#T3){ref-type="table"}). We noted a drop in timely vaccinations between the first and third doses, irrespective of the vaccination schedule and vaccine type in use.

###### Time delays in the receipt of doses of hepatitis B vaccine for children aged 12--60 months in 47 countries, by national hepatitis B vaccination schedule

  Vaccination schedule^a^ and vaccine type   Country                            First dose                 Third dose             
  ------------------------------------------ ---------------------------------- ------------ ------------- ------------ --------- -------------
  **Weeks 0, 4, 13**                                                                                                              
  Monovalent                                 Maldives                           2 042        427 (21)                   2 036     1 868  (92)
  **Weeks 0, 4, 26**                                                                                                              
  Monovalent                                 Republic of Moldova                1 040        66 (6)                     1 062     355 (33)
  **Weeks 0, 6, 14**                                                                                                              
  Monovalent                                 Nigeria                            3 661        2 823 (77)                 3 043     1 615 (53)
  **Weeks 0, 6, 26**                                                                                                              
  Monovalent                                 Armenia                            1 016        170 (17)                   943       554 (59)
  **Weeks 0, 9, 17**                                                                                                              
  Monovalent                                 Azerbaijan                         760          244 (32)                   622       279 (45)
  Monovalent                                 Tajikistan                         2 981        433 (15)                   2 750     545 (20)
  **Weeks 0, 9, 22**                                                                                                              
  Monovalent                                 Kyrgyzstan                         2 244        125 (6)                    2 054     348 (17)
  **Weeks 0, 9, 26**                                                                                                              
  Monovalent                                 Albania                            798          99 (12)                    758       96 (13)
  **Weeks 4, 8, 12**                                                                                                              
  Tetravalent                                United Republic of Tanzania        3 367        996 (30)                   3 223     1 868 (58)
  Pentavalent                                Uganda                             801          371 (46)                   700       528 (75)
  **Weeks 6, 10, 14**                                                                                                             
  Monovalent                                 Bangladesh                         3 583        818 (23)                   3 428     1 792 (52)
  Monovalent                                 Cameroon                           1 745        366 (21)                   1 607     641 (40)
  Monovalent                                 Gabon                              793          211 (27)                   627       320 (51)
  Monovalent                                 Lesotho                            739          115 (16)                   643       266 (41)
  Monovalent                                 Pakistan                           560          185 (33)                   508       322 (63)
  Monovalent                                 Swaziland                          1 347        94 (7)                     1 315     337 (26)
  Monovalent                                 Timor-Leste                        1 971        740 (38)                   1 853     1 112 (60)
  Bivalent                                   Benin                              2 076        398 (19)                   1 877     879 (47)
  Tetravalent                                Madagascar                         1 993        524 (26)                   1 891     882 (47)
  Tetravalent                                Mozambique                         5 282        2 361 (45)                 4 764     3 586 (75)
  Pentavalent                                Burundi                            1 335        180 (13)                   1 298     517 (40)
  Pentavalent                                Cambodia^b^                        2 443        368 (15)                   2 286     850 (37)
  Pentavalent                                Comoros                            1 088        255 (23)                   1 032     537 (52)
  Pentavalent                                Côte d'Ivoire                      1 363        396 (29)                   1 120     647 (58)
  Pentavalent                                Democratic Republic of the Congo   914          255 (28)                   780       337 (43)
  Pentavalent                                Ghana                              1 587        220 (14)                   1 539     579 (38)
  Pentavalent                                Kenya                              2 413        451 (19)                   2 302     804 (35)  
  Pentavalent                                Liberia                            862          256 (30)                   749       461 (61)
  Pentavalent                                Malawi                             2 341        664 (28)                   2 309     1 327 (57)
  Pentavalent                                Mali                               309          127 (41)                   275       188 (68)
  Pentavalent                                Namibia                            814          69 (8)                     796       173 (22)
  Pentavalent                                Niger                              1 148        400 (35)                   1 062     707 (67)
  Pentavalent                                Rwanda                             2 386        167 (7)                    2 351     569 (24)
  Pentavalent                                Senegal                            2 277        617 (27)                   2 084     1 154 (55)
  Pentavalent                                Sierra Leone^b^                    2 072        555 (27)                   1 891     1 168 (62)
  Pentavalent                                Zambia                             6 136        1 883 (31)                 5 697     3 438 (60)
  **Weeks 9, 13, 17**                                                                                                             
  Monovalent                                 Jordan                             3 598        381 (11)                   3 523     1 264 (36)
  Pentavalent                                Congo                              1 155        161 (14)                   1 014     315 (31)
  Pentavalent                                Burkina Faso                       3 447        502 (15)                   3 350     1 188 (35)
  **Weeks 9, 17, 26**                                                                                                             
  Monovalent                                 Egypt                              4 612        220 (5)                    4 093     474 (12)
  Monovalent                                 Colombia^b^                        8 431        1 194 (14)                 8 161     2 510 (31)
  Pentavalent                                Bolivia (Plurinational State of)   4 631        1 112 (24)                 4 292     1 849 (43)
  Pentavalent                                Guyana                             1 044        202 (19)                   1 018     416 (41)
  Pentavalent                                Honduras                           6 516        464 (7)                    6 445     1 673 (26)
  Pentavalent                                Peru^b^                            4 225        453 (11)                   4 065     1 251 (31)
  **Weeks 13, 17, 22**                                                                                                            
  Pentavalent                                Zimbabwe                           1 246        341 (27)                   1 082     574 (53)
  **Overall (weighted counts)**              N/A                                108 626      23 626 (22)                101 542   43 548 (43)

N/A: not applicable.

^a^ Schedule is the target weeks after birth to administer the first, second and third doses of vaccine.

^b^ Vaccination schedule in these countries includes a birth dose of hepatitis B vaccine (monovalent), i.e. four doses in total.

Notes: Data were extracted from the most recent demographic and health survey in each country (survey year range: 2005--2014). The results are based on children for whom vaccination dates were available (recorded on vaccination cards). We included children who received vaccinations before the recommended age (early vaccinations) in the denominator. Delayed vaccination was defined as a vaccine dose received more than 4 weeks after the target week in the national vaccination schedule. Estimates of early vaccinations are not shown in the table. The following countries reported \> 10% of children vaccinated before the recommended age for the first dose: Burkina Faso (23%), Cameroon (12%), Congo (16%), Democratic Republic of the Congo (14%), Egypt (17%), Guyana (13%), Madagascar (11%), Mali (11%), Sierra Leone (20%) and Timor-Leste (16%). The following countries reported \> 10% of children vaccinated before the recommended age for the third dose: Azerbaijan (50%), Plurinational State of Bolivia (12%), Colombia (12%), Kyrgyzstan (60%), Nigeria (12%) and Tajikistan (56%).

For the 47 countries overall, the median of the median delays for the first vaccine dose was 1.0 week, and the 75th percentile was 3.6 weeks, i.e. in 25% of the countries the median delay was more than 3.6 weeks. For the third dose, the delays were more than twice as long ([Table 4](#T4){ref-type="table"}). The country-specific distribution of ages at vaccination had long tails, and delays at the 90th percentile were at least twice as long as the 75th percentile ([Table 5](#T5){ref-type="table"}, available at <http://www.who.int/bulletin/volumes/95/3/16.178822>). Overall, WHO African Region countries tended to have lower vaccination coverage and poorer timing compared with countries in the Americas and Europe. Delays were recorded even in countries with high coverage, such as Bangladesh and Burkina Faso. We found a weak positive correlation (Spearman rho = 0.28; *P* = 0.05) between vaccination timing and coverage. [Fig. 3](#F3){ref-type="fig"} shows the timing and the corresponding coverage of the third vaccine dose for each of the 47 countries, using data from vaccination cards.

###### Time delays in the receipt of doses of hepatitis B vaccine for children aged 12--60 months across 47 countries

  Percentiles     First dose delay percentiles, weeks         Third dose delay percentiles, weeks                    
  --------------- ------------------------------------- ----- ------------------------------------- -- ----- ------- ------
  25th            0.0                                   0.4   1.8                                      0.7     2.4   6.1
  50th (median)   0.3                                   1.0   3.6                                      1.4     3.7   9.3
  75th            0.6                                   2.0   5.0                                      2.4     5.7   13.2

Notes: Total number of children (weighted counts) were 108 626 (first dose) and 101 542 (third dose). Data were extracted from the most recent demographic and health survey in each country (survey year range: 2005--2014). Delayed vaccination was a vaccine dose received more than 4 weeks after the target week in the national vaccination schedule.

###### Time delays, in percentiles, in the receipt of doses of hepatitis B vaccine for children aged 12--60 months in 47 countries, by national hepatitis B vaccination schedule

  Vaccination schedule^a^ and vaccine type   Country or median for vaccination schedule   First dose          Third dose                                              
  ------------------------------------------ -------------------------------------------- ------------ ------ ------------ ----- ----- -- ------ ------ ------ ------ ------
  **Weeks 0, 4, 13**                                                                                                                                                  
  Monovalent                                 Maldives                                     2042         0.1    0.3          1.0   0.9      2036   5.9    7.9    11.9   6.0
  **Weeks 0, 4, 26**                                                                                                                                                  
  Monovalent                                 Republic of Moldova                          1040         0.0    0.0          0.1   0.1      1062   0.6    2.3    5.6    5.0
  **Weeks 0, 6, 14**                                                                                                                                                  
  Monovalent                                 Nigeria                                      3661         1.7    4.7          9.4   7.7      3043   1.0    5.4    14.7   13.7
  **Weeks 0, 6, 26**                                                                                                                                                  
  Monovalent                                 Armenia                                      1 016        0.1    0.3          0.6   0.4      943    2.0    6.1    13.0   11.0
  **Weeks 0, 9, 17**                                                                                                                                                  
  Monovalent                                 Azerbaijan                                   760          0.0    0.0          4.4   4.4      622    0.9    3.1    10.1   9.3
  Monovalent                                 Tajikistan                                   2981         0.0    0.0          0.3   0.3      2750   −3.3   −1.1   3.0    6.3
  N/A                                        Median                                       1541         0.0    0.0          2.4   2.4      1499   −1.2   1.0    6.6    7.8
  **Weeks 0, 9, 22**                                                                                                                                                  
  Monovalent                                 Kyrgyzstan                                   2244         0.0    0.1          0.1   0.1      2054   −6.1   −3.3   2.1    8.3
  **Weeks 0, 9, 26**                                                                                                                                                  
  Monovalent                                 Albania                                      798          0.1    0.1          0.3   0.2      758    0.4    1.1    2.7    2.3
  **Weeks 4, 8, 12**                                                                                                                                                  
  Tetravalent                                United Republic of Tanzania                  3367         0.9    2.3          5.1   4.3      3223   2.4    5.6    11.9   9.4
  Pentavalent                                Uganda                                       801          2.7    4.1          7.9   5.2      700    4.6    8.6    17.7   13.1
  N/A                                        Median                                       2084         1.8    3.2          6.5   4.7      1962   3.5    7.1    14.8   11.3
  **Weeks 6, 10, 14**                                                                                                                                                 
  Monovalent                                 Bangladesh                                   3583         1.0    2.6          4.3   3.3      3428   2.6    4.7    8.7    6.1
  Monovalent                                 Cameroon                                     1745         0.3    1.1          3.9   3.6      1607   1.1    3.1    7.7    6.6
  Monovalent                                 Gabon                                        793          0.4    1.1          5.1   4.7      627    1.9    4.7    13.0   11.1
  Monovalent                                 Lesotho                                      739          0.4    1.1          2.9   2.4      643    2.0    3.7    7.9    5.9
  Monovalent                                 Pakistan                                     560          1.0    2.7          6.1   5.1      508    3.1    5.9    13.4   10.3
  Monovalent                                 Swaziland                                    1347         0.1    0.4          1.3   1.2      1315   0.7    1.7    4.6    3.9
  Monovalent                                 Timor-Leste                                  1971         0.4    3.0          7.6   7.1      1853   2.6    6.1    12.9   10.3
  Bivalent                                   Benin                                        2076         0.1    1.0          3.4   3.3      1877   1.3    4.0    9.4    8.1
  Tetravalent                                Madagascar                                    1993        0.4    2.0          4.7   4.3      1891   1.9    4.0    9.3    7.4
  Tetravalent                                Mozambique                                   5282         2.7    4.0          7.7   5.0      4764   4.6    9.3    19.3   14.7
  Pentavalent                                Burundi                                      1335         0.6    1.1          2.6   2.0      1298   2.0    3.4    6.6    4.6
  Pentavalent                                Cambodia^b^                                  2443         0.6    0.9          2.7   2.1      2286   1.6    3.0    6.9    5.3
  Pentavalent                                Comoros                                      1088         0.4    1.1          4.0   3.6      1032   2.0    5.0    13.6   11.6
  Pentavalent                                Côte d'Ivoire                                1363         0.6    2.0          5.6   5.0      1120   2.9    5.9    14.3   11.4
  Pentavalent                                Democratic Republic of the Congo             914          0.3    1.7          5.0   4.7      780    1.3    3.7    9.7    8.4
  Pentavalent                                Ghana                                        1587         0.3    1.1          3.1   2.9      1539   1.4    3.3    6.6    5.1
  Pentavalent                                Kenya                                        2413         0.1    1.0          3.4   3.3      2302   0.9    2.6    6.6    5.7
  Pentavalent                                Liberia                                      862          0.4    1.7          5.0   4.6      749    2.1    6.4    17.0   14.9
  Pentavalent                                Malawi                                       2341         0.7    2.4          5.0   4.3      2309   2.6    5.6    11.0   8.4
  Pentavalent                                Mali                                         309          0.7    2.9          8.3   7.6      275    3.9    7.3    19.4   15.6
  Pentavalent                                Namibia                                      814          0.0    0.4          1.0   1.0      796    0.6    1.4    3.9    3.3
  Pentavalent                                Niger                                        1148         0.6    2.6          7.0   6.4      1062   3.1    7.3    16.6   13.4
  Pentavalent                                Rwanda                                       2386         0.4    1.0          2.3   1.9      2351   1.1    2.4    4.4    3.3
  Pentavalent                                Senegal                                      2277         0.6    1.7          4.7   4.1      2084   2.1    5.3    11.1   9.0
  Pentavalent                                Sierra Leone^b^                              2072         0.0    1.3          4.9   4.9      1891   2.4    7.3    17.0   14.6
  Pentavalent                                Zambia                                       6136         0.4    2.0          5.4   5.0      5697   2.4    6.3    15.0   12.6
  N/A                                        Median                                       1587         0.4    1.5          4.7   4.2      1573   2.0    4.7    10.4   8.4
  **Weeks 9, 13, 17**                                                                                                                                                 
  Monovalent                                 Jordan                                       3598         0.0    0.7          2.1   2.1      3523   1.6    3.1    6.1    4.6
  Pentavalent                                Congo                                        1155         −0.1   0.4          2.7   2.9      1014   0.7    2.1    5.6    4.9
  Pentavalent                                Burkina Faso                                 3447         −0.4   0.4          2.4   2.9      3350   0.7    2.7    6.4    5.7
  N/A                                        Median                                       3447         −0.1   0.4          2.4   2.9      3350   0.7    2.7    6.1    4.9
  **Weeks 9, 17, 26**                                                                                                                                                 
  Monovalent                                 Egypt                                        4612         −0.3   0.1          0.9   1.2      4093   0.3    0.9    2.3    2.0
  Monovalent                                 Colombia^b^                                  8431         −0.1   0.3          2.1   2.3      8161   0.4    1.7    6.1    5.7
  Pentavalent                                Bolivia (Plurinational State of)             4631         −0.1   1.0          4.3   4.4      4292   0.4    3.0    10.0   9.6
  Pentavalent                                Dominican Republic^b^                        1434         −0.1   0.1          1.4   1.6      1224   1.0    2.1    6.0    5.0
  Pentavalent                                Guyana                                       1044         −0.1   1.0          3.6   3.7      1018   1.1    3.3    8.1    7.0
  Pentavalent                                Honduras                                     6516         −0.3   0.0          1.0   1.3      6445   0.6    1.7    4.7    4.1
  Pentavalent                                Peru^b^                                      4225         −0.3   0.0          1.4   1.7      4065   0.3    1.7    5.7    5.4
  N/A                                        Median                                       4612         −0.1   0.1          1.4   1.7      4093   0.4    1.7    6.0    5.4
  **Weeks 13, 17, 22**                                                                                                                                                
  Pentavalent                                Zimbabwe                                     1246         0.3    1.7          4.9   4.6      1082   1.1    5.3    14.0   12.9

IQR: interquartile range; N/A: not applicable.

^a^ Schedule is the target week after birth to administer the first, second and third doses of vaccine.

^b^ Vaccination schedule in these countries includes a birth dose of hepatitis B vaccine (monovalent), i.e. four doses in total.

Notes: Data were extracted from the most recent demographic and health survey (survey year range: 2005--2014) in each country. Denominators are weighted. Delayed vaccination was vaccine dose received more than 4 weeks after the target week in the national vaccination schedule. Negative values indicate vaccination before the recommended target week; 0.0 indicates no delays.

![Scatter plot of country-specific coverage and timing of third dose of hepatitis B vaccine for children aged 12--60 months in 47 countries](BLT.16.178822-F3){#F3}

[Table 6](#T6){ref-type="table"} (available at <http://www.who.int/bulletin/volumes/95/3/16.178822>) shows the descriptive statistics for the pooled weighted sample used in the regression models. [Table 7](#T7){ref-type="table"} shows pooled multivariable regression models for delays in the first and third doses. After adjusting for covariates, delays in the first dose for vaccination schedules starting at 6 weeks of age (aOR: 0.81; 95% CI: 0.75 to 0.88) and at 9 weeks of age (aOR: 0.50; 95% CI: 0.46 to 0.53) were lower than for vaccination schedules with a birth dose. Vaccination schedules starting at 4 weeks and at 13 weeks of age tended to have higher odds of delays. Combination vaccines tended to have lower odds of delays in the first dose than did the monovalent vaccine (aOR: 0.76; 95% CI: 0.71 to 0.81). In a separate pooled model, when controlling for the timing of the receipt of the first dose, we observed higher odds of delays in the third dose if the first dose was delayed than if it was on time (aOR: 22.89; 95% CI: 20.99 to 24.97).

###### Descriptive characteristics of children aged 12--60 months included in the study on the association between vaccination schedules (vaccine type) and hepatitis B vaccination timing in 47 countries

  Characteristic                         No. (%) of children
  ---------------------------------- -------------------------
  **Child's sex**                    
  Male                               105 351 (51)
  Female                             102 095 (49)
  **Residence**                      
  Urban                              75 470 (36)
  Rural                              131 976 (64)
  **Birth order**                    
  First child                        53 614 (26)
  Second or higher child             153 832 (74)
  **Place of delivery**              
  Home                               64 666 (31)
  Institution                        138 963 (67)
  Missing data                       3817 (2)
  **Mother's education**             
  None                               55 907 (27)
  Primary                            67 851 (33)
  Secondary or higher                83 642 (40)
  Missing                            45 (\< 1)
  **Mother's marital status**        
  Unmarried                          55 614 (27)
  Married                            151 832 (73)
  **Wealth index^a^**                
  Poorest                            46 606 (22)
  Poor                               44 791 (22)
  Medium                             42 917 (21)
  Rich                               39 492 (19)
  Richest                            33 641 (16)
  **Family size, mean (95% CI)**     6.62 (6.57 to 6.67)
  **Country income level^b^**        
  Low                                68 224 (33)
  Lower-middle                       103 415 (50)
  Upper-middle                       35 807 (17)
  **Total (weighted)**               207 446 (100)
  **Population size (unweighted)**   211 643

CI: confidence interval.

^a^ Wealth index as an indicator of economic status of the household, categorized into five quintiles ranging from the poorest 20% to the richest 20%.

^b^ Country income level as per the World Bank.[@R22]

Notes: Missing observations (non-responses) were excluded from the analysis. Numbers are weighted counts.

###### Multivariable pooled regression analysis for the association between vaccination schedule and vaccine type on hepatitis B vaccination timing among children aged 12--60 months in 47 countries

  Variable                                First dose     Third dose                                                  
  ------------------------------------- -------------- -------------- ------------------------ ---------- ---------- -----------------------
  **Vaccination schedule start week**                                                                                
  ≤ 1                                     14 437         4 353          Ref.                     9 565      5 602      Ref.
  4                                       3 972          1 353          0.91 (0.80 to 1.03)      3 810      2 355      1.14 (1.00 to 1.30)
  6                                       44 647         12 525         0.81 (0.75 to 0.88)      43 932     23 336     0.97 (0.91 to 1.03)
  9                                       29 151         4 482          0.45 (0.41 to 0.50)      33 273     10 688     0.50 (0.46 to 0.53)
  13                                      791            338            1.11 (0.92 to 1.34)      1 016      565        1.21 (1.03 to 1.42)
  **Vaccine type**                                                                                                   
  Monovalent                              37 763         8 305          Ref.                     32 297     14 007     Ref.
  Combination                             60 055         14 746          0.76 (0.71 to 0.81)     59 299     28 538   0.99 (0.94 to 1.05)

aOR: adjusted odds ratio; CI: confidence interval; Ref.: reference category.

^a^ The number of children included in the analyses were adjusted for the covariates stated below.

Notes: Data were extracted from the most recent demographic and health survey (DHS) in each country (survey year range: 2005--2014). Total number of children (weighted counts) were 97 818 (first dose) and 91 596 (third dose). Total observations were 100 167 (first dose) and 93 807 (third dose). Denominators vary across variables because of item non-response. Model was adjusted for child's age (yearly increments), sex, residence (urban versus rural), birth order of the child (1 versus \> 1), mother's age (yearly increments), mother's marital status (married versus unmarried), mother's education (none, primary, secondary and higher), birth place (home versus institutional), household wealth index (5 quintiles of wealth; poorest, poor, medium, rich, richest), family size (increments per member), country income level as per the World Bank (categorized as low income, lower-middle income and upper-middle income;[@R22] and survey year. The variance inflation factors for the multivariable models were 1.06 for first dose (delayed) and 1.09 for third dose (delayed), respectively, indicating the absence of multicollinearity among explanatory variables.

Discussion
==========

Our analysis of survey data from 47 low- and middle-income countries, inhabited by around 1.2 billion people,[@R29] showed a wide variation in hepatitis B vaccination coverage and timing across countries. The results highlight differences in vaccination implementation, and in adherence to national immunization schedules. This may reflect differences in barriers to immunization, in inequities in health-care delivery and access, as upper-middle-income countries tended to have better coverage and timing than lower-middle and low-income countries. Most countries had fairly high coverage (\> 80%), in particular for the first dose, and delivered vaccines on time. Although this finding is encouraging, in most countries coverage decreased and delays increased with subsequent doses, irrespective of a country's specific vaccination schedule. Crucially, vaccination coverage was low (\< 50%) and vaccinations were delayed in populous countries that are highly endemic for HBV infection, such as Nigeria.

Despite WHO recommendations on hepatitis B vaccination within 24 hours,[@R8] only 13 countries in our analysis reported using a birth dose, with wide variations in its coverage and timing. Due to existing sociocultural, financial, infrastructural and logistic constraints on vaccine delivery, many countries do not require the birth dose to be strictly administered within 24 hours of birth.[@R26]^,^[@R30] A major challenge, particularly in highly endemic, resource-poor countries with a high proportion of home deliveries, is ensuring the timely administration of the birth dose to every child irrespective of where he or she is born.[@R30]^,^[@R31]

Most countries where the HBV epidemic is concentrated have adopted the three-dose combination vaccine delivered at 6, 10 and 14 weeks.[@R30] Our analysis gave some indication that vaccination delays were lower with vaccination schedules starting at 6 or 9 weeks of age compared with those starting at or before 1 week of age, and with combination vaccines as compared with monovalent vaccines. This might be attributable to increased compliance by vaccine recipients due to the reduced number of injections and fewer visits required to health-care facilities.[@R32] That said, administering combination vaccinations at 6 or 9 weeks of age, while cost-effective and simple, cannot prevent vertical and early horizontal transmission.[@R30]

It has been suggested that, due to the predominantly horizontal routes of HBV transmission in Africa, the benefit of implementing a birth dose would not justify the necessary financial, human resource and infrastructure investments.[@R33] This is based on the premise that perinatal transmission is not a major factor in HBV transmission due to the lower prevalence of hepatitis B e-antigen (HBeAg) positivity in pregnant women in Africa. However, studies suggest that up to 38% of pregnant African women with chronic HBV are positive for HBeAg and hence at high risk of transmitting infection to their infants.[@R34]^--^[@R36] Data on the epidemiology of HBV, particularly transmission routes,[@R30] and on the benefits of birth-dose vaccination are scarce in Africa.[@R37] Nevertheless, in our view, the benefits of giving a birth dose in the African setting deserve consideration, due to the high burden of HBV infection[@R2] and the known high risk of infection and chronicity associated with perinatal and early horizontal infections. From a policy perspective it is important to examine current country-level modes of HBV transmission in tandem with existing vaccination schedules so that recommendations can be adapted to existing disease transmission patterns.

We found lower compliance with national schedules for the second and third vaccine doses and a weak correlation of timing with coverage. This implies that even in countries with relatively high coverage, children who achieve complete vaccination may spend a considerable period of time with no or incomplete protection. This is particularly concerning in countries with a high burden of infection.[@R3]

Our analysis also indicates that the third dose of vaccine is more likely to be delayed among those who received a delayed first dose. This suggests that prioritizing timely first vaccinations could result in the timely receipt of successive doses[@R38] and avert delays that would require catch-up regimens. Given the existent challenges in providing hepatitis B vaccination in resource-poor settings, catch-up regimens might decrease the likelihood of the timely completion of the hepatitis B vaccination series.[@R38]^,^[@R39] This underscores the need to incorporate the monitoring of vaccination timing, in addition to coverage, into vaccination programmes.

Interrupting transmission routes for HBV warrants comprehensive strategies to prevent mother-to-child transmission and to deliver adequate and timely immunoprophylaxis in newborns[@R40] and infants.[@R41]^,^[@R42] In remote, resource-constrained settings, integrating vaccine administration with assisted home deliveries and employing out-of-cold-chain strategies might be possible solutions to improve timely vaccination coverage.[@R43]^--^[@R45] Furthermore, mathematical models, calibrated to country-specific HBV epidemiology might be useful to quantify the burden of infection attributable to delayed vaccinations. In this context, models could be developed to assess the infections and deaths averted by prioritizing timely vaccinations that use alternative vaccination schedules and diverse outreach strategies.

Limitations
-----------

The main limitation of this analysis is related to the available data from DHS. The survey years varied substantially across countries, and therefore caution is warranted when interpreting international comparisons.[@R20] Most surveys were fairly recently conducted -- the median survey year was 2012-- and provide useful insights into the quality (timing) and quantity (coverage) of current hepatitis B vaccination programmes. However, some of the older surveys, notably in the Republic of Moldova and Swaziland, may not reflect the current situation.

The distribution of ages at vaccination are only crude indicators of the timing issue, since each country's contribution was determined by the size of its survey sample, which varied among countries and did not reflect actual population sizes.

Our coverage estimates vary to some extent from available estimates[@R46] due to some aspects of our method: the use of DHS survey data, the age groups included and the reliance on documented vaccinations. Multisurvey prospective data were unavailable for most countries. We could not therefore assess temporal changes in vaccination measures and the effects of changes in vaccination schedules or vaccine types on the studied outcomes. Furthermore, some vaccination schedules included in the analysis were used only by a small number of countries, which impeded any conclusions about the effects of specific schedules. We restricted our analysis to established vaccination schedules. This might lead to underestimates or overestimates depending on the uptake of newer vaccines and schedules by countries. Data on vaccination service providers were not available which might have provided valuable insights into the issue of hepatitis B vaccination timing.

We excluded undocumented vaccinations from the analysis and therefore coverage and delays may be underestimates, since undocumented vaccinations including lost or misplaced vaccination cards were not captured.[@R19] Vaccination information was based only on maternal recall in approximately 30% of the observations, with higher figures in some countries (such as the Democratic Republic of the Congo and Nigeria). However, no noteworthy differences in coverage were detected for most countries when we included maternal reports (data are available from the corresponding author).

A disadvantage of cross-sectional studies is the potential for survivor bias. Our analysis did not include deceased children since the included surveys did not record vaccination data for this sub-group. We might have overestimated vaccination measures slightly since it is unlikely that deceased children would have better vaccination parameters than surviving children.[@R47] The cross-sectional nature of the data also precluded our drawing causal inferences. Additionally, it is likely that there was residual confounding that was not adjusted for in our models. To enable more in-depth analyses, future surveys need to incorporate sufficiently detailed questions on barriers to immunization, e.g. vaccine availability in the health system, and on parental and provider vaccination practices.

Lastly, the surveyed countries were not randomly sampled. Hence the external validity of the results for other low- and middle-income countries might be limited, particularly for those using different vaccination schedules than those in the current analysis. The available data were primarily from countries in the WHO African, European and Americas Regions, with limited data from the Eastern Mediterranean, South-East Asian and Western Pacific Regions.

Conclusion
==========

The substantial inequities in the implementation and adherence to national immunization schedules for hepatitis B vaccine underscore the continued need for strengthening immunization systems. Strategies that focus on the timely initiation of hepatitis B immunization might lead to the timely receipt of successive doses and hence improve overall coverage. Our findings indicate that timing should be incorporated as a performance indicator of routine immunization services, as a complement to coverage assessments.
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